Citadel Advisors
REPL icon

Citadel Advisors’s Replimune Group REPL Stock Holding History

Citadel Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89M Sell
247,000
-3,200
-1% -$24.5K ﹤0.01% 6181
2025
Q4 		$2.43M Sell
250,200
-4,800
-2% -$40.8K ﹤0.01% 5561
2025
Q3 		$1.07M Buy
255,000
+93,400
+58% +$597K ﹤0.01% 7399
2025
Q2 		$1.5M Buy
161,600
+151,900
+1,566% +$1.33M ﹤0.01% 6256
2025
Q1 		$94.6K Buy
9,700
+1,700
+21% +$21K ﹤0.01% 11558
2024
Q4 		$96.9K Sell
8,000
-2,200
-22% -$26.7K ﹤0.01% 11533
2024
Q3 		$112K Buy
10,200
+1,000
+11% +$10.2K ﹤0.01% 10970
2024
Q2 		$82.8K Sell
9,200
-9,000
-49% -$62.7K ﹤0.01% 11166
2024
Q1 		$149K Buy
18,200
+600
+3% +$4.92K ﹤0.01% 10774
2023
Q4 		$148K Sell
17,600
-86,800
-83% -$1.01M ﹤0.01% 10406
2023
Q3 		$1.79M Buy
104,400
+91,600
+716% +$1.8M ﹤0.01% 5424
2023
Q2 		$297K Buy
12,800
+5,900
+86% +$115K ﹤0.01% 9073
2023
Q1 		$122K Sell
6,900
-78,600
-92% -$1.87M ﹤0.01% 10981
2022
Q4 		$2.33M Buy
85,500
+300
+0.4% +$6.23K ﹤0.01% 5201
2022
Q3 		$1.47M Buy
85,200
+3,700
+5% +$70.6K ﹤0.01% 6198
2022
Q2 		$1.43M Buy
81,500
+68,600
+532% +$1.13M ﹤0.01% 6230
2022
Q1 		$219K Buy
+12,900
New +$243K ﹤0.01% 11307
2021
Q3 		– Sell
-11,400
Closed -$438K – 14509
2021
Q2 		$438K Buy
+11,400
New +$390K ﹤0.01% 10358

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's REPL Position: Q1 2026 in Review

Citadel Advisors increased its Replimune Group (REPL) stake by 152% in Q1 2026, buying an estimated $1.84M and bringing the position to 398,729 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #5228.

Citadel Advisors first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $44.4M in Q4 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Citadel Advisors held 398,729 shares of Replimune Group worth $3.05M as of Q1 2026.
  • Citadel Advisors bought 240,370 Replimune Group shares in Q1 2026, an estimated $1.84M.
  • Replimune Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5228 holding.
  • Citadel Advisors first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Citadel Advisors's Replimune Group position peaked at $44.4M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.